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Abstract.  A  novel membrane protein from rat brain 
synaptic vesicles with an apparent 29,000 Mr (p29) 
was characterized.  Using monospecific polyclonal anti- 
bodies, the distribution of p29 was studied in a variety 
of tissues by light and electron microscopy and immu- 
noblot analysis.  Within the nervous system, p29 was 
present in virtually all nerve terminals.  It was selec- 
tively associated with small synaptic vesicles and a 
perinuclear region corresponding to the area of the 
Golgi complex.  P29 was not detected in any other 
subcellular organelles including large dense-core vesi- 
cles. The distribution of p29 in various subcellular 
fractions from rat brain was very similar to that of 
synaptophysin and synaptobrevin. The highest enrich- 
ment occurred in purified small synaptic vesicles. Out- 
side the nervous system, p29 was found only in endo- 
crine cell types specialized for peptide hormone 
secretion.  In these cells, p29 had a distribution very 
similar to that of synaptophysin. It was associated with 
microvesicles of heterogeneous size and shape that are 
primarily concentrated in the centrosomal-Golgi com- 
plex area.  Secretory granules were mostly unlabeled, 
but their membrane occasionally contained small la- 
beled evaginations.  Immunoisolation of subcellular or- 
ganelles from undifferentiated PC12 ceils with anti- 
synaptophysin antibodies led to a concomitant enrich- 
ment of p29, synaptobrevin, and synaptophysin, fur- 
ther supporting a colocalization of all three proteins. 
P29 has an isoelectric point of ,',,5.0 and is not 
N-glycosylated. It is an integral membrane protein and 
all antibody binding sites are exposed on the cytoplas- 
mic side of the vesicles. Two monoclonal antibodies 
raised against p29 cross reacted with synaptophysin, 
indicating the presence of related epitopes. P29, like 
synaptophysin, was phosphorylated on tyrosine 
residues by endogenous tyrosine kinase activity in 
intact vesicles. 
C 
HEMICAL signaling  between neurons is mediated by 
regulated exocytosis of secretory vesicles that contain 
quanta  of neurotransmitters.  At least two types of 
secretory vesicles coexist in neurons:  small synaptic vesicles 
(SSVs),~ which contain  only nonpeptide neurotransmitters, 
and large dense-core vesicles (LDCVs), which contain neu- 
roactive peptides, other polypeptides, and some nonpeptide 
transmitters.  The molecular mechanisms involved in the bio- 
genesis of these organelles and in their life cycles, including 
exocytosis, are still largely unknown (for review see Reich- 
ardt and Kelly,  1983;  Kelly,  1988;  De Camilli  and Jahn, 
1990). To understand these processes in more detail, it is es- 
sential to obtain detailed information  about the properties of 
the protein components present in their membranes. 
Recently,  several  proteins have been identified  in mam- 
malian brain that are associated with virtually all SSVs inde- 
pendent of their neurotransmitter  content (De Camilli  and 
1. Abbreviations used in this paper: LDCV, large dense-core vesicle; SSV, 
small synaptic vesicle. 
Jahn,  1990).  These include the synapsins-a family of ho- 
mologous proteins associated with the cytoplasmic surface of 
the vesicles (De Camilli and Greengard, 1986)-and several 
integral  membrane  proteins-synaptophysin  (Jahn  et  al., 
1985; Wiedenmann and Franke,  1985), synaptobrevin (Bau- 
mert et al.,  1989; Siidhof et al.,  1989a;  [the two isoforms 
are also referred to as VAMP 1 and VAMP 2] Trimble et al., 
1988; Elferink et al., 1989), p65 (Matthew et al., 1981), and 
SV2 (Buckley and Kelly, 1985). Some of these proteins have 
been thoroughly characterized,  and the primary structure of 
the synapsins (Sfidhof et al.,  1989b), synaptophysin  (Leube 
et al., 1987; Sfidhof et al., 1987; Buckley et al., 1987), and 
synaptobrevin  (Sfidhof et al.,  1989a;  Trimble et al.,  1988; 
Elferink  et al.,  1989) has been elucidated. 
In  neurons,  the  synapsins,  synaptophysin,  and  synap- 
tobrevin are selectively concentrated on SSVs (Navone et al., 
1984, 1986; Banmert et al., 1989). Outside the nervous sys- 
tem, the synapsins are largely absent, whereas synaptophy- 
sin, synaptobrevin, p65, and SV2 are present in certain endo- 
crine tissues.  In these tissues, the subeellular localization  of 
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Franke, 1985;  Navone et al.,  1986).  It is associated with a 
popllafion of pleomorphic microvesicles (synaptic-like micro- 
vesicles) and absent from the membrane of secretory gran- 
ules (Navone et al.,  1986; Wiedenmalm et al., 1988; John- 
ston et al., 1989b). These microvesicles are concentrated at 
microtubule-organizing centers at the tmns-side of the Golgi 
complex, can fuse with the plasmalemma,  and are labeled 
by extracellular tracers.  They most probably represent  recy- 
cling organelles (Navone et al., 1986; Johnston et al., 1989b). 
Based on these findings, we have suggested that synaptic-like 
microvesicles in endocrine cells are related to SSVs in new 
rons (Navone et al.,  1986;  De Camilli and Jahn,  1990). 
In the present study,  we report the characterization  of a 
new membrane protein of 29,000 Mr present in SSVs.  The 
protein is immunologically related to synaptophysin,  under- 
goes endogenous tyrosine phospborylation in SSV fractions, 
and is expressed by both neurons and endocrine cells. 
Materials and Methods 
Materials 
Nitrocellulose membrane filters  (pore size 0.2 /tm) were obtained from 
Schieicher & Schuell, Inc. (Dassel, FRG).  125I-labeled  donkey anti-rabbit 
Ig (3.7 MBq/ml) and [T;2P]ATP (37 Mlkl/ml  ) was purchased from Amer- 
sham  Buchier  GmbH  (Braunschweig,  FRG).  Affinity-purified  goat 
anti-mouse IgG,  coupled to horseradish peroxidase,  was  from Bio-Rad 
Laboratories (Munich, FRG). Rhodamine-conjngated  goat anti-rabbit IgGs 
were from Organon Teknika (Malvern, PA); colloidal gold-conjngnted goat 
anti-rabbit IgGs (GAR 5) was  from Janssen Pharmaceutica (Olen, Bel- 
gium); and monoclonal anti-phosphotyrosine antibody was  from Boeh- 
ringer  Mannheim  GmbH (Mannheim, FRG). Protein A-colloidal gold com- 
plexes were prepared as described in Slot and Geuze (1983).  Ampholines 
(pH 3.5-10 and pH 5-7) were from Pbarmacia Fine Chemicals (Freiburg, 
FRG); recrystallized  sodium cholate was from Calbiochem-Behring Corp. 
(Frankfurt, FRG); and pepride N-glycosidase  F (N-Glycanase)  was from 
Genzyme (Boston, MA). Eupergit CIZ beads (1 /~m diameter) were pur- 
chased from R6hm Pbarma (Darmstadt, FRG). PCI2 cells (C 251) were 
kindly provided by Drs. G. D. Borasio and H. Thoenen (Max-Planck-in- 
sritute for Psychiatry, Marriusried, FRG). All other reagents were ofanalyri- 
cal grade and obtained from standard commercial sources. 
Immunochemical Techniques 
Monoclonal and polyclonal  antibodies were genera  .t.~t. essentially as de- 
scribed earlier, using p29 as an antigen which was l~rified by preparative 
elactrophoresis (Baumert et al.,  1989).  The polyclonal  rabbit serum was 
affinity-purified  using p29 excised from preparative immunoblots as im- 
munondsorbent (Olmstedt, 1987).  Monoclonal and polyclonal  antibodies 
against synaptophysin and synaptohi~vin were prepared as described (Jahn 
et al.,  1985; Baumert et al.,  1989). 
For the preparation of immunobeads, antibodies were immobilized on 
nonporous methacrylate microbends using a recently developed procedure 
(Burger et al.,  1989). For coupling of IgM-antibodies (CI  13.1), the pro- 
tocol was slightly modified.  IgM was enriched from ascites by fracrionated 
ammonium sulfate precipitation (30-50%) and extensively dialyzed against 
150 mM NaCI.  500 mg of Eupergit CIZ methacrylate micmbeads were 
washed once with water and incubated with 10 mg IgM (final concentration 
1 mg/mi) for 45 rain at 20°C.  Inactivation of remaining binding sites and 
washing was performed as described (Burger  et al.,  1989). 
For immunoprecipitarion of p29, synaptic vesicle protein (final concen- 
trarion 0.4 mg/ml) was solubilized in 150 mM NaCI,  10 mM sodium phos- 
phate, pH 7.2, containing 1% (wt/voi) sodium cholate.  The extract was in- 
cubated for 30 min on ice and spun for 20 min at 50,000 rpm in a Beckman 
Instruments, Inc. (Fullerton, CA) TLA 100.2 rotor. The supernatant was re- 
moved, and 20/zl C1 13.1 immunobends were added followed by end-over- 
end rotation for 90 min at 4°C. Thereafter, the beads were sedimented by 
centrifugarion  at 12,000 g for 30 s, washed three times with solubilization 
buffer, and finally resusponded  in electrophoresis sample buffer. 
SubceUular Fractionation 
Synaptic vesicles  were prepared essentially as described earlier (Nagy et 
al., 1976; Huttnor et aL, 1983; Jahn et al., 1985). Briefly, cerebral cortices 
of 20 rats were homogenized in 150 ml of sucrose buffer (0.32 M sucrose, 
0.1 mM PMSF,  2/~g/ml pepstarin A). The homogenate (H) was spun for 
10 min at 800 g, yielding a pellet (Pj). The superuatant was centrifuged for 
15 min at 9,200 g. The resulting pellet was washed once with sucrose buffer, 
yielding a crude synaptosomal pellet (P2). The supernntant was centrifuged 
at  165,000 g  for  1  h,  yielding pellet P3  and  supernatant $3.  P2  was 
resuspended in 12 ml of sucrose buffer and lysed by addition of 9 vul of dis- 
tilled water, followed by homogenization.  Hepes/NaOH buffer was added 
to a final concentration of 10 mM at pH 7.4. After 30 min of incubation, 
the fraction was spun at 25,000 g for 20 min (pellet LP,), and the superna- 
rant was further centrifuged for 2 h at 165,000 g, yielding a crude synaptic 
vesicle pellet (LP2) and a supernntant (LS2). Vesicles were further purified 
by centrifugarion of LP2 on a continuous sucrose density gradient, yielding 
fraction SGV. This was chromatographed on controlled pore glass beads, 
resulting in purified synapric vesicles (fraction CPG). For preparative pur- 
poses,  the preparation method described by Hell et al. (1988) was used. 
Synaptophysin-containing  microvesicles  were isolated from PC12 cells 
using a modification  of the recently described immunoisolation procedure 
for synaptic vesicles (Burger et al., 1989). Cells were grown under standard 
conditions (Greene and Tischler,  1976). After harvesting, cells were col- 
lected by centrifngntinn (,~3  x  107 cells) and homogenized  in 0.5 ml of 
0.32 M sucrose, 3 mM imidazule, pH 7.4, 0.1 mM PMSF, 2 ~g/ml pepsterin 
A by repetitively  passing through a 27-gange needle. The homogenate was 
adjusted to 1 ml and centrifuged for 10 min at 10,000 g. To I ml of superna- 
rant, 50 mg of C 7.2 immunobends were added as a  100-~d solution in 10 
mM Tris-Cl, pH 7.4, 150 mM NaCI, and incubation was allowed to proceed 
for 1 h at 4°C under slow rotation.  Beads were collected by centrifngation 
for 10 rain at 320 g and washed three rimes in 0.32 M sucrose,  10 mM Tris- 
CI, pH 7.4, 0.1 mM PMSF, 2 ttg/ml pepstarin A. The final pellet was in- 
cubated for 15 rain in 100 ~tl of the washing solution containing 2% SDS. 
The beads were removed by centrifugation, and an aliquot of the supernatant 
was used for SDS-PAGE and immunoblotting. 
Immunocytochemistry 
For light microscopy  immunocytochemistry,  tissue fixation, prepamrion of 
10-~tm-thick frozen tissue sections, and immunefluorescence  staining were 
performed as described (De Camilli et al.,  1983a;  Navone et al.,  1986). 
Immunogold labeling of agarose-embedded  homogenates of bovine tissues 
(hypothalamus,  anterior pituitary,  and adrenal medulla) and of rat brains, 
was performed as described (De Camilli et al., 1983b; Navone et al., 1986). 
A lyric fixation method was used for the brain tissues (to open resealed nerve 
endings) and an isoosmotic fixation method for the endocrine tissues (for 
a discussion of lytic and nonlytic fixation see De Camilli et al., 1983b). Un- 
less indicated  otherwise,  afffinity-purified rabbit antibody directed against 
p29 was used. 
Other Analytical Techniques 
SDS-PAGE was performed according to Laemmli (1970).  Immunobiotting 
was carried out according to Towbin et al. (1979), using either mdioindin- 
ated (dilution 1:200) or horseradish pemxidase-coupled secondary antibod- 
ies as detection systems (Jahn et al., 1985). Phase partition in Triton X-II4 
was carried out according to Bordier (1981). Phosphorylarion of vesicle pro- 
teins was performed essentially as described by Hirano et al. (1988). Protein 
was determined either by the method of Bradford (1976) or by a modified 
Lowry procedure (Peterson,  1977). 
Results 
Preparation and Characterization of  Antibodies 
Directed against p29 
Electrophoretic  analysis  of membrane  proteins  extracted 
from a highly purified SSV fraction revealed the presence of 
a protein band with an apparent 29,000 Mr (not showo; see 
Baumert et al., 1989). This protein band, referred to as p29, 
was purified by preparative electrophoresis and used for im- 
munization of a rabbit and mice. 
The Journal of Cell Biology, Volume 110, 1990  1286 Figure L Characterization of  polyclonal and monoclonal antibodies directed against p29 by immtmoblotting. 2/~g of  synaptie vesicle protein 
per lane was separated by SDS-PAGE on a 12% gel and blotted onto nitrocellulose filters. (a) Labeling with rabbit antibody (affinity 
purified; see Materials and Methods) diluted 1:200. (b) Dilution series of monoclonal antibody Cl 7.1 (unprocessed aseites fluid). (c) 
Dilution series of rnonoclonal antibody C1 13.1 (unprocessed aseites fluid). In b and c, the dilution factor of the aseites (x 10  -2) is indi- 
cated on top of each lane. For visualization, the strips were subsequently incubated with a species-specific anti-Ig antibody (linked to 
horseradish peroxidase) followed by development with 4-chloro- l-napthol. Arrowheads in b and c point to the position of an additional 
immunoreactive band of 38,000 Mr (synaptophysin; see tex0. 
Rabbit polyclonal antibodies were affinity purified from 
serum by blot adsorption. The antibodies reacted with a sin- 
gle band  of an  apparent 29000  Mr  in  an  immunoblot of 
vesicle proteins (Fig. 1 a). In addition, two monoclonal anti- 
bodies (clones C1 7.1 and C1 13.1, both IgM) were generated 
from  two  independent  fusions.  Both  antibodies  reacted 
specifically with two protein bands of 29,000 and 38,000 Mr 
(Fig. 1, b and c). The identity of the 29,000-Mr protein, rec- 
ognized  by  the  polyclonal  and  monoclonal  antibodies, 
respectively, was confirmed by immunoprecipitation from a 
detergent extract of rat brain homogenate. In further immu- 
noprecipitation experiments, it was shown that the 38000- 
Mr  protein  band  is  identical  to  synaptophysin  (data  not 
shown). To examine the degree of cross-reactivity with syn- 
aptophysin, various dilutions of the monoclonal antibodies 
el 7.1 and C1 13.1 were tested by immunoblotting (Fig. 1 b). 
At higher dilutions (e.g.,  10,000-fold), both antibodies dis- 
played a preference for p29, showing a stronger reaction with 
p29 than with synaptophysin. These results indicate that both 
proteins share similar, although not identical, epitopes. 
Cellular and SubceUular Localization of  p29 
within the Nervous System 
To analyze the precise localization of p29 within the nervous 
system, the affinity-purified rabbit antibodies were used in 
immunocytochemical experiments. Immunofluorescence per- 
formed on frozen sections from various regions of the rat 
central nervous system revealed a  punctate pattern of im- 
munoreactivity (Fig. 2, a  and b). This pattern of immuno- 
reactivity was very similar to that produced by antibodies 
directed against other SSV proteins (De Camilli et al., 1983a; 
Jahn et al., 1985; Navone et al., 1986; Baumert et al., 1989). 
This is shown in Fig. 2, b and c, by double labeling of the 
same brain stem section for p29 and synaptophysin. It was 
previously shown that the puncta correspond to individual 
nerve terminals. P29 immunofluorescence was also detect- 
able on a network of thread-like structures that is present in 
neuronal perikarya and extends into the dendrites (Fig. 2 a). 
This labeling pattern is characteristic of the Golgi complex 
of neurons (De Camilli et al., 1986). A widespread distribu- 
tion of p29 was also found in the peripheral nervous system. 
lmmunoreactive nerve terminals were found in the skeletal 
muscle (Fig. 2, dandf) and, in the muscle layers of  the stom- 
ach wall,  the vas deferens, and the Auerbach plexus (not 
shown). P29 was also concentrated in sensory nerve endings 
(Fig.  2 f) and  in terminals of the posterior pituitary (not 
shown), which corresponds with the staining pattern obtained 
for other small synaptic vesicle proteins (De Camilli et al., 
1988; Navone et al.,  1989). 
The subcellular localization of p29 in the nervous tissue 
was  analyzed by various complementary methods.  Fig.  3 
shows agarose-embedded cell fragments of rat and bovine 
brain homogenates that were immunogold labeled for p29. 
Gold label was only found in nerve terminals and was almost 
exclusively localized on SSVs. A few larger vesicular struc- 
tures were labeled,  which probably corresponds to  inter- 
mediate stages in the life cycle of SSVs (Fig. 3  c). Similar 
structures were also labeled using antibodies directed against 
synaptophysin (Navone et al., 1986) and synaptobrevin (Bau- 
mert et al., 1989). Other membranous elements in nerve ter- 
Baumert et al. P29, a  Vesicle Membrane Phosphoprotein  1287 Figure 2. Localization of p29 in nerve terminals of the central and peripheral nervous system. Immunofluorescence of frozen rat tissue 
sections. (a) Brain stem neuron. The profile of the neuronal perikaryon is outlined by bright puncta of immunoreactivity that correspond 
to nerve endings forming axosomatic synapses. Other large puncta visible in the field represent nerve terminals of axodendritic synapses. 
Immunoreactivity is also visible on thrend-like structures in the neuronal cytoplasm (arrows), which correspond to elements of the Golgi 
complex. (b and c) Double staining of the same brain stem section for p29 (b; afffinity-purified  rabbit antibody) and for synaptophysin 
(c; monoclonal antibody C 7.2). The patterns of immunoreactivity are identical, suggesting a very close colocalization of  the two proteins. 
Immunoreactive nerve terminals outline the profile of neuronal perikarya. Arrows point to the same nerve terminals in b and c. (d and 
e) Double staining of  the same skeletal muscle motor end plates for p29 (d; immunorhodamine) and for alpha-bungarotoxin (e; fluorescein- 
conjugated toxin), which binds to the acetylcholine receptor and therefore outlines the morphology of the synapse. (f) Immunostaining 
of skeletal muscle showing immunoreactlve sensory nerve endings in a muscle spindle. Bars: (a)  10 #m; (b-f) 20 #m. 
minals,  which probably represent tubules and cisternae of 
the  endoplasmic  reticulum,  were  not  labeled.  Also,  no 
significant labeling of LDCVs or of the presynaptic plas- 
rnalemma was observed (Fig. 3, b, d, e, arrowheads). Virtu- 
ally all nerve terminals with a disrupted plasma membrane 
(i.e., with SSVs accessible to antibodies; see De Camilli et 
al.,  1983b) were labeled. 
These results were supported by subcellular fractionation 
experiments. Immunoblot analysis of various fractions ob- 
tained during the isolation of SSVs from rat cerebral cortex 
showed that p29 has a distribution very similar to that of the 
SSV  proteins  synaptophysin and  synaptobrevin,  with  the 
highest enrichment in the purified vesicle fraction (Fig. 4). 
Distribution of  p29 outside the Nervous System 
Outside the nervous system, significant levels of p29  im- 
munoreactivity were observed only in various endocrine tis- 
sues specialized for regulated exocytotic secretion of pro- 
reins. Immunofluorescence  of frozen tissue sections revealed 
p29 immunoreactivity in the anterior pituitary (Fig. 5 a), in 
the adrenal medulla (Fig. 5 b), in the intermediate pituitary, 
in the endocrine pancreas, in the parathyroids, and in sparse 
endocrine cells of the gut (not shown).  P29 immunoreac- 
tivity was also found in cell lines derived from endocrine tis- 
sues (e.g., PC12 cells and insulinoma cells [Rin cells]). In 
all these cells, immunoreactivity was present throughout the 
cytoplasm but was concentrated primarily in a paranuclear 
region corresponding to the location of the Golgi complex 
(Fig. 5, arrows). Similar fluorescence  patterns were obtained 
after double labeling the same cells for p29 and for synap- 
tophysin (not shown), although the Golgi-like staining pat- 
tern was more intense for p29 than for synaptophysin. 
Tissues which were both nonneuronal and nonendocrine 
did not contain any detectable amounts of p29.  This was 
confirmed by immunoblotting (Fig. 6). 
The Journal of Cell Biology, Volume  110, 1990  1288 Figure 3. Localization of p29 in nerve endings of rat brain (a) and bovine hypothalami (b--e). Immunogold labeling of ~se-embedded 
cell fragments obtained by mild homogenization, a  shows selective labeling of SSVs in nerve terminals. LDCVs, visible in b, d, and e 
(arrowheads), are unlabeled.  An SSV completely decorated by gold particles is outlined by a black circle in b. An arrow in c points to 
a labeled membranous profile larger than SSVs. An asterisk in d marks an unlabeled vacuole, possibly an element of the endoplasmic reticu- 
lure.  Note the lack of labeling on the plasma membrane. Bars, 200 nm. 
SubceUular Localization of  p29 in Endocrine Cells 
We have previously shown that synaptophysin in endocrine 
cells is localized on a microvesicle population (synaptic-like 
microvesicles)  distinct  from secretory granules  (Navone et 
al.,  1986). Since the distribution of p29 in nonneuronal cells 
described in the previous section is similar to that of synap- 
tophysin (Navone et al.,  1986), it was of interest to determine 
whether  p29 has a  similar  subcellular  localization. 
Fig.  7  shows a  series of electron micrographs illustrating 
the localization of p29 by immunogold in subcellular parti- 
Figure 4. Automdingraphy of an immunoblot of various sub- 
cellular fractions obtained during the isolation of rat brain 
synaptic vesicles labeled with afffinity-purified  serum anti- 
bodies for synaptophysin  (dilution  1:2~00; top) p29 (dilution 
1:300; middle), and synaptobrevin (dilution 1:300; bottom). 
5 ttg of each fraction was separated by SDS-PAGE on a 13 % 
gel and blotted onto nitrocellulose  membrane filters.  The 
blot was cut between the position of synaptophysin, p29, and 
synaptobrevin, respectively, and each part was stained with 
the  respective antibody  followed by incubation  with  t~I- 
labeled  secondary  antibody  and  autoradiography.  To  in- 
crease sensitivity, the exposure time for synaptobrevin was 
twice as long as that for p29 and synaptophysin. (Lanes 1-10) 
H, PI, P2, P3, $3, LPI, LP2,  LS2, SGV, and CPG, respec- 
tively.  See Materials and Methods for details. 
Baumert et al. P29, a Vesicle Membrane Phosphoprotein  1289 Figure 5. Localization  of  p29 by immunofluorescence  in endocrine 
tissues. Frozen sections of the rat anterior pituitary (a) and adrenal 
gland (b). The adrenal gland cells of  the adrenal medulla (AM), but 
not cells of  the adrenal cortex (AC), are positive. Note  the presence 
of moderate levels of immunoreactivity throughout the cytoplasm 
and an intense accumulation of immunoreactivity in the proximity 
of the nucleus (arrows) corresponding to the Golgl-centrosomal 
area. Bars, 20/~m. 
cles of bovine anterior pituitary (Fig. 7, a and b) and adrenal 
medulla (Fig. 7, c-e). P29 immunoreactivity was found pri- 
marily on microvesicles (Fig. 7, a-c),  while no significant 
labeling was observed on secretory granules.  Occasional- 
ly, immunogold labeling was observed on relatively small 
dense-core structures and on small membrane evaginations 
of larger granules (Fig.  7  d).  Other labeled elements in- 
cluded large irregularly shaped vesicles with a clear core and 
tubular  extensions of vacuolar structures  (possibly  endo- 
somes; Fig. 7 e). The strong labeling of the entire grannie 
membrane  by  antibodies  directed  against  the  chromaltin 
granule membrane protein cytochrome b561 (Fig. 7f) showed 
that the absence of  labeling for p29 on the granule membrane 
is not due to inhibition of antibody access to binding sites. 
These results show that the vesicle population containing 
p29 has a morphological appearance similar to the popula- 
tion containing synaptophysin (Navone et al.,  1986).  This 
suggests  that both proteins are coloealized on the same en- 
domembrane system. To test this hypothesis, synaptophysin- 
containing vesicles were purified by "mamunoisolation from 
undifferentiated PC12 cells and analyzed for the presence of 
p29.  For  this  purpose,  monoclonal  antibodies  directed 
against synaptophysin were immobilized on the surface of 
nonporous methacrylate microbeads that were then used for 
organelle immunoadsorption. This method allows the one- 
step  purification  of  synaptophysin-containing  organelles 
from crude cell extracts. AS shown in Fig. 8, p29 coenriched 
with synaptophysin in the immunoadsorbed fraction. Similar 
enrichment was also found for synaptobrevin. The majority 
of  each protein was removed from the starting fraction by this 
procedure (not shown), suggesting that all three proteins are 
colocalized in the same vesicle pool of PC12 cells. However, 
the relative abundance of the proteins in PCl2 cells is differ- 
ent from that in the brain. When compared with synaptophy- 
sin, both p29 and synaptobrevin are significantly less abun- 
dant in endocrine cells (data not shown). 
Molecular Properties of  p29 
The isoelectric point of p29 was determined by isoelectric 
focusing followed by  SDS-PAGE  and  immunoblotting of 
SSV  proteins.  It was found to be in the range of 5.0 (not 
shown), which is more acidic than that of synaptobrevin but 
similar to that of synaptophysin. 
To analyze the nature of the association of p29 with the 
vesicle membrane, phase partition of synaptic vesicle pro- 
teins was performed using the detergent Triton X-114 (Bor- 
dier,  1981). As shown in Fig. 9 a, p29 was selectively en- 
riched in the detergent phase (lane D),  suggesting that it 
contains hydrophobic, detergent-binding domains. This is in- 
dicative of the presence of transmembrane segments. Since 
antibodies to p29 bind to the outer surface of SSVs (see elec- 
tron micrographs above), a portion of the molecule is proba- 
bly exposed on the cytoplasmic side. Furthermore, we inves- 
tigated  whether  p29  is  modified  by  N-glycosylation.  A 
detergent extract of SSVs was treated with peptide N-glycos- 
idase F to remove N-linked sugar moieties. As shown in Fig. 
9 b, the electrophoretic mobility of  p29 remained unchanged 
whereas synaptopbysin (which is known to be N-glycosylated; 
Navone et ai., 1986; Rehm et al., 1986) was partially shifted 
to an apparent 34,000 M, (compare control sample [lane C] 
with endoglycosidase-treated sample [lane El). Similar re- 
sults were obtained after treating PC12 cells with tunicamy- 
cin to inhibit core glycosylation  (not shown). Together, these 
results indicate that p29 is not N-glycosylated  in neurons and 
PC12 cells. 
In a final series of experiments, we investigated whether 
p29,  like  synaptophysin,  undergoes  endogenous  tyrosine 
phosphorylation. This possibility was suggested by recent 
studies reporting the endogenous tyrosine phosphorylation 
of synaptophysin and of additional proteins in the molecular 
mass range of 26-30 kD in synaptic vesicle fractions (Pang 
et al.,  1988;  Hirano et al.,  1988).  To examine whether the 
30-kD band described in these studies is identical with p29, 
a  vesicle-enriched fraction was incubated with [-/32p]ATP 
under conditions optimal for tyrosine phosphorylation. As 
shown in Fig. 10 a, a number of protein bands were labeled, 
indicating phosphorylation by endogenous protein kinases. 
Three of the hands (corresponding to 38,000,  29,000,  and 
24,000  Mr)  contain phosphotyrosine (Pang  et  al.,  1988; 
Hirano et al.,  1988;  our unpublished observations). Three 
Figure  6t  Immunoblot of various rat  tissue  homogenates (10 
~tg/lane), labeled for p29 with afffinity-purified  serum antibodies, 
using radiolabeling with an ~25I-linked  secondary antibody for de- 
tection as described in the legend to Fig. 4. For comparison, the 
upper part of the blot was cut off and labeled for synaptophysin 
using the same protocol. To increase sensitivity, the strip labeled 
for p29 was exposed six times longer than that for synaptophysin. 
(Lanes 1-7) Cortex, cerebellum, spinal cord, skeletal  muscle, liver, 
kidney, and lung, respectively. 
The Journal  of Cell Biology,  Volume 110, 1990  1290 Figure  7. Subcellular particles of bovine anterior pituitary  (a and b) and adrenal medulla (c-f)  immunolabeled for p29 (a-e)  or for 
cytochrome b~l (f). Immunogold labeling of homogenates embedded in agarose. Arrows point to membranous profiles immunolabeled 
for p29. p29 immunolabeling is localized on microvesicles (a-c) and on the tubular evaginations of a larger membranous organelle that 
may represent an endosome (e). Secretory granule membranes are unlabeled. The vacuole with a partially dense core shown in d may 
represent an immature granule. (f) Cytochrome b~l immunoreactivity  is abundant on the entire secretory granule membrane. Bars, 200 nm. 
Figure 8. Autoradiography of an immunoblot of  a PCI2 cell homog- 
enate (lanes A; 10/zg of protein) and of a membrane fraction iso- 
lated using anti-synaptophysin monoclonal antibody C 7.2 coupled 
to methacrylate beads 0anes B). SDS-PAGE, immunoblotting, and 
visualization were performed as given in the legend to Fig. 4. (Left) 
Labeling for p29; (upper right) labeling for synaptophysin; (lower 
right) labeling for synaptobrevin. 
identical  bands  were  recognized  by  a  phosphotyrosine- 
specific monoclonal antibody (Fig.  10 b,  lane  tyr-P).  To 
demonstrate that the 29,000-Mr  band is identical with p29, 
the vesicle fraction was extracted with cholate at the end of 
the phosphorylation reaction and  subjected to high-speed 
centrifugation. P29 was immunoprecipitated from the result- 
ing  supernatant  using  monoclonal antibody C1  13.1 con- 
jugated to methacrylate beads, which recognizes p29 as well 
as synaptophysin. As shown in Fig. 10 c, both p29 and synap- 
tophysin were selectively immunopreeipitated (lane 13.1) and 
shown to contain phosphotyrosine (lane tyr-P). We conclude 
that p29 is a substrate for endogenous tyrosine kinase. 
Discussion 
In the present study, we have characterized p29, a new mem- 
brane protein of SSVs. P29 is a  nonglycosylated, integral 
Baumert et al. P29,  a  Vesicle Membrane  Phosphoprotein  1291 Figure 9. Molecular properties of p29. (a) Detergent binding ana- 
lyzed by phase partition in Triton X-II4.2/zg of synaptic vesicle 
proteins (fraction CPG) was used for the partition followed  by SDS- 
PAGE on a 12% gel and transferred to nitrocellulose membranes. 
The blot was incubated with affinity-purified  rabbit antibody against 
p29 followed by incubation with  ~25I-labeled secondary antibody 
and autoradiography. (lane A) Aqueous phase; (lane D) detergent 
phase. (b) Analysis of p29 for the presence of N-glycosylation by 
endoglycosidase treatment. 15/~g of vesicle proteins was extracted 
with Triton X-114 and then treated with peptide N-glycosidase F 
(N-glycanase) according to the manufacturer's instructions (lanes 
E). A control sample (lanes C) was processed in parallel with the 
enzyme  being omitted from the reaction mixture. The samples were 
separated by SDS-PAGE  on 16% gels and labeled in parallel for p29 
and synaptophysin (SP) as described in the legend to Fig. 4. The 
arrowhead points to the position of the deglycosylated form of syn- 
aptophysin. 
membrane protein with 29,000 Mr and an acidic isoelectric 
point. Portions of the molecule are exposed at the cytoplas- 
mic surface of the vesicle as indicated by antibody binding 
(see Fig. 6) and protease digestion experiments (our unpub- 
lished observations). 
P29 appears to have some structural similarity with synap- 
tophysin. Both monoclonal antibodies raised against dena- 
tured p29 cross react with synaptophysin in immunoblotting 
and immunoprecipitation assays.  The high degree of speci- 
ficity in both assay systems suggests that this cross-reactivity 
is not due to a nonspecific side reaction, which is known to 
occur with antibodies of the IgM subclass.  However, it can 
be clearly excluded that p29 is a breakdown product of syn- 
aptopbysin.  The polyclonal antibody used in our study is 
monospecific for p29, and both monoclonal antibodies dis- 
play a preference for p29 (see Fig. 1). Furthermore, none of 
the available anti-synaptophysin antibodies, including those 
specific for internal epitopes (Jahn et al.,  1985; Johnston et 
al., 1989a), react with p29 (our unpublished observations). 
A few reports have been published concerning proteins of 
brain coated and synaptic vesicles with molecular weights 
similar to that of  p29. Analysis of  membrane proteins present 
in brain coated vesicles revealed the presence of a 29000- 
Mr protein that was probably derived from synaptic vesicles 
(Pfeffer and Kelly,  1985;  Wiedenmann et al.,  1985).  Fur- 
thermore, a  membrane protein of 30,000 Mr has been de- 
scribed in guinea pig brain synaptic vesicles (Obata et al., 
1987).  Since  synaptic  vesicles contain  several membrane 
proteins of similar molecular weight (our unpublished obser- 
vations), further work is required to determine whether any 
of these proteins are related to p29. 
Within the nervous system, p29 is present in virtually all 
nerve terminals where it is selectively associated with the 
membranes of SSVs. Thus, p29 appears to be a new member 
of a group of proteins, including the synapsins, synaptophy- 
sin, and synaptobrevin, that are present in all SSVs irrespec- 
tive of the specific neurotransmitter content (for review see 
De Camilli and Jahn,  1990). The SSV proteins SV2 (Buck- 
Icy and Kelly, 1985) and p65 (Matthew et al.,  1981) appar- 
ently share this widespread distribution, although the idea 
that synaptophysin and p65 are colocalized has been disputed 
(Volknandt et al., 1988). The absence of p29 from the mem- 
branes of  LDCVs confirms our previous observations that the 
membrane compositions of SSVs and LDCVs are dissimilar 
(Navone et al., 1984, 1986; Baumert et al., 1989). This indi- 
cates that SSVs do not originate from recycling LDCV mem- 
branes as suggested by other investigators (Lowe et al., 1988; 
Kelly, 1988; Boarder, 1989) unless extensive protein sorting 
within the nerve terminal is involved. Rather, the data add 
further experimental  support  to  our  view  that  SSVs  and 
Figure 10.  Tyrosine phosphorylation of p29. (a) 
Autoradiograph of  a vesicle-enriched fraction after 
phosphorylation with [732p]ATP and SDS-PAGE 
(7-15 % gradient gel). (b) Immunoblots of  a vesicle 
fraction after phosphorylation with unlabeled ATP 
and separation by SDS-PAGE (13% gel).  (Lane 
13.1) Labeling with monoclonal antibody C1 13.1; 
(lane tyr-P)  labeling with  anti-phosphotyrosine 
monoclonal antibody. Both antibodies were visu- 
aiized with a horseradish peroxidase procedure. 
(c) Immunoprecipitation of  p29 and synaptophysin 
from a cholate extract of synaptic vesicles after 
phosphorylation with unlabeled ATP followed by 
SDS-PAGE and immunoblotting of the immuno- 
precipitate. For the precipitation, monoclonai antibody C1 13.1, immobilized on rnethacrylate microbeads, was used. (Lane 13.1) Labeling 
with monoclonal antibody C1 13.1; (lane tyr-P) labeling with anti-phosphotyrosine monoclonal antibody. Both antibodies were visualized 
with a horseradish peroxidase procedure. The position of synaptophysin and p29 in b and c is indicated by arrowheads. The asterisks in 
c indicate the positions of the light chain of C1  13.1 that was partially removed from the immunobeads and reacted with the secondary 
antibody used in this assay. No signals with synatophysin or p29 were obtained with either antibody when beads coupled to control Ig 
were used (not shown). 
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cycles (Navone et al.,  1986; De Camilli and Jahn,  1990). 
Outside the nervous system, p29 was detected only in cells 
specialized for endocrine secretion by regulated exocytosis 
(neuroendocrine cells). Again, its subcellular localization is 
very similar to that of synaptophysin (Navone et al.,  1986) 
and synaptobrevin(cf. Fig.  10; Baumert et al.,  1989), indi- 
cating  a  colocalization  of  all  three  proteins.  This  was 
confirmed by their parallel enrichment upon immunoisola- 
tion of subeellular membranes.  Structures labeled for p29 
were mostly microvesicles with clear  content.  The  mem- 
branes of secretory granules were unlabeled, with the excep- 
t.ion of occasional labeling of focal evaginations.  This may 
indicate that segregation of p29 from secretory granule pro- 
teins is completed during  granule maturation  after leaving 
the Golgi complex. Protein segregation by focal evagination 
of membrane patches has been shown to be involved in the 
secretory pathway of liver cells where the asialoglycoprotein 
receptor  is  separated  from  secretory  proteins  by  such  a 
mechanism (Geuze et al.,  1987). 
Together,  these results are consistent with our previous 
suggestion that the presence of SSV proteins in endocrine 
cells reflects the presence of a population of microvesicles 
(synaptic-like  microvesicles) distinct  from secretory gran- 
ules (Navone et al.,  1986;  De Camilli and Jahn,  1990).  It 
should be noted,  however, that the absence of SSV mem- 
brane proteins from secretory granules has recently been dis- 
puled.  Based on immunoisolation  or subeellular  fraction- 
ation experiments, it was reported that synaptophysin, p65, 
and SV2 are common to SSVs and to endocrine  secretory 
granules (Lowe et al., 1988; Obendorf et al., 1988). At pres- 
ent,  it is difficult to explain this discrepancy. It is possible 
that  synaptopbysin,  and  also the  other  SSV proteins,  are 
present in the membranes of mature secretory granules at a 
concentration below the detection limit of our immunocyto- 
chemical techniques.  However, the secretory granule frac- 
tions may be contaminated with synaptic-like microvesicles 
that  remain  attached  to  secretory  granules  after  isolation 
(e.g., Fig. 7). The latter interpretation  is supported by our 
recent observation that synaptophysin-containing microvesi- 
cles  can  be  separated  from  chromaffin  granules  by  im- 
munoadsorption, leaving behind a granule fraction contain- 
ing high amounts of cytochrome b56~ but no synaptophysin 
(our unpublished observations). 
The function of synaptic-like microvesicles in endocrine 
cells remains to be established.  Recent studies on synapto- 
physin-containing  microvesicles in PC12 cells and in fibro- 
blasts  transfected  with  the  cDNA  of synaptophysin  have 
provided  important  insights  into  the  relationship  of these 
membranes with other vesicle-routing pathways. It appears 
that synaptic-like microvesicles are organelles that recycle 
between the region of the Golgi complex and the plasma- 
membrane (Johnston et al.,  1989b). When synaptophysin is 
expressed in Chinese hamster ovary cells, which naturally do 
not express the protein, it is targeted to a microvesicle popu- 
lation similar to that involved in the recycling of transferrin 
receptors. These findings raise the possibility that synaptic- 
like microvesicles in endocrine cells may be related to vesi- 
cles that recycle plasmalemma receptors. SSV exocytosis and 
recycling in synaptic terminals could then be the neuronal 
adaptation of a general membrane recycling pathway. 
The function of p29 remains unknown.  However, an im- 
portant clue is provided by our finding that p29 can undergo 
endogenous tyrosine phosphorylation in SSV fractions, add- 
ing another element of similarity to synaptophysin, which is 
the major substrate for tyrosine kinase activity in synaptic 
vesicles (Pang  et al.,  1988).  It is likely that the protoon- 
cogene pp60  ~'~ is responsible for this phosphorylation since 
pp60  ~= is present in synaptic vesicles (Hirano et al.,  1988). 
The concentration of pp61Y  -'~ and of some of the major sub- 
strates for tyrosine phosphorylation in SSVs is intriguing.  It 
was suggested that pp60  ~'~ expression in the nervous sys- 
tem is correlated not only with cell proliferation but also with 
the development or maturation  of neuronal  processes and 
synaptic contacts (Cotton and Brugge,  1983;  Sorge et al., 
1984). Tyrosine phosphorylation of p29 and synaptophysin 
may, therefore, be involved in a major regulatory mechanism 
during the life cycle of SSVs and/or in controlling the assem- 
bly of SSV clusters at presynaptic sites. 
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